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Summary
Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on safety and efficacy of manganese compounds as feed additives for all animal species: manganous chloride, tetrahydrate; manganous sulphate, monohydrate; manganous oxide; manganese chelate of amino acids, hydrate; manganese chelate of glycine, hydrate. The safety assessment is based on the assumption that the current maximum total contents of manganese authorised in feed are respected.
All manganese compounds under application are considered safe for all animal species/categories.
The mean manganese intake of the European population includes already the manganese from animal products and does not pose a toxicological concern. The effect of dietary manganese fed to animals on tissue concentrations is limited. Supplementation of feed with the manganese compounds under assessment would consequently not affect consumer exposure and is of no concern for consumer safety.
All manganese compounds are considered as eye irritants, the manganese chelate of glycine and the manganese chelate of amino acids as irritants to skin and the latter one as dermal sensitiser. However, the presence of nickel in all additives may induce contact dermatitis. Exposure to manganese in dust of all additives and to nickel (except manganous chloride and manganous oxide) poses a risk to users by inhalation.
The use of the manganese compounds under assessment in animal nutrition for all animal species is not expected to pose a risk to the environment.
The manganese compounds under assessment are recognised as efficacious sources of manganese in meeting animals' requirements.
The FEEDAP Panel made some recommendations concerning (i) the monitoring of mercury and nickel in the additives; (ii) the characterisation of manganese chelates of amino acids, hydrate; (iii) the protection of the user; and (iv) the use of manganese-based additives in water for drinking, which is seen as critical to ensure compliance with the legally established maximum supply of manganese to animals.
Introduction

Background and Terms of Reference 1
Regulation (EC) No 1831/2003
2 establishes the rules governing the Community authorisation of additives for use in animal nutrition. In particular, Article 4 (1) of that Regulation lays down that any person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an application in accordance with Article 7. Article 10(2) of that Regulation also specifies that for existing products within the meaning of Article 10(1), an application shall be submitted in accordance with Article 7, at the latest 1 year before the expiry date of the authorisation given pursuant to Directive 70/524/EEC for additives with a limited authorisation period, and within a maximum of 7 years after the entry into force of this Regulation for additives authorised without a time limit or pursuant to Directive 82/471/EEC.
The European Commission (EC) received a request from TREAC EEIG (Trace Elements Authorisation Consortium European Economic Interest Grouping) 3, 4 for (i) authorisation of a new use and/or (ii) reevaluation of authorisation, of manganese-containing additives when used as feed additives for all animal species (category: Nutritional additives; functional group: compounds of trace elements).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the application to the European Food Safety Authority (EFSA) as an application under Article 4(1) (authorisation of a feed additive or new use of a feed additive) and under Article 10(2) (re-evaluation of an authorised feed additive). EFSA received directly from the applicant the technical dossier in support of this application. The particulars and documents in support of the application were considered valid by EFSA as of 30 May 2012.
According to Article 8 of that Regulation, EFSA, after verifying the particulars and documents submitted by the applicant, shall undertake an assessment in order to determine whether the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the safety for the target animals, consumer, user and the environment and on the efficacy of the product 'Manganous chloride, tetrahydrate', 'Manganous sulphate, monohydrate', 'Manganous oxide'; 'Manganese chelate of amino acids, hydrate' and 'Manganese chelate of glycine, when used under the proposed conditions of use (see Section 3.1.7). 
Additional information
Manganese (Mn) is an abundant element which makes up about 0.1% of the Earth's crust. It exists in a variety of oxidation states, Mn 2+ and Mn 3+ being the most biologically important. The elemental (metal) form of manganese does not occur naturally in the environment; however, manganese is a component of over 100 minerals (ATSDR, 2012) .
Manganese is an essential nutrient in humans and animals that plays a role in bone mineralisation, regulation of protein and energy metabolism, cellular protection from damaging free radical species and formation of glycosaminoglycans (Wedler, 1994) . Manganese acts as both (i) a constituent of metalloenzymes, e.g. arginase, pyruvate carboxylase and manganese-superoxide dismutase (NRC, 1989; Keen and Zidenberg-Cher, 1990; Wedler, 1994) and (ii) as activator of enzymes involved with either a catalytic or regulatory function (e.g. transferases, decarboxylases, hydrolases) (Wedler, 1994) . In its activating capacity, manganese can bind either to a substrate (such as adenosine triphosphate) or directly to a protein, thereby causing conformational changes (Keen and ZidenbergCher, 1990 The Scientific Committee on Animal Nutrition (SCAN) issued a report on the use of manganomanganic oxide in feedingstuffs (EC, 2002) . EFSA issued an opinion on the safety of the chelated forms of iron, copper, manganese and zinc with synthetic feed grade glycine (EFSA, 2005) and three opinions on a manganese chelate of hydroxy analogue of methionine (EFSA, 2008a (EFSA, , 2009a (EFSA, , 2010a . In the frame of re-evaluation EFSA has delivered three opinions on manganese-based additives: manganese chelate of amino acids, hydrate (EFSA FEEDAP Panel, 2013a) , manganous oxide (EFSA FEEDAP Panel, 2013b , 2013c and manganous sulphate monohydrate (EFSA FEEDAP Panel, 2013c) .
A compilation of risk assessments carried out on manganese and its compounds, including opinions from EFSA Panels other than the FEEDAP Panel, is in Appendix A. A list of authorisations of manganese compounds in the EU, other than as feed additive, is reported in Appendix B.
Data and methodologies
Data
The present assessment is based on data submitted by the applicant in the form of a technical dossier 9 in support of the authorisation request for the use of five manganese compounds (manganous chloride, tetrahydrate; manganous oxide; manganous sulphate, monohydrate; manganese chelate of amino acids, hydrate; manganese chelate of glycine, hydrate) as feed additives. The FEEDAP Panel used the data provided by the applicant together with data from other sources, such as previous risk assessments by EFSA or other expert bodies, scientific papers, other scientific reports and experts' elicitation knowledge, to deliver the present output.
EFSA commissioned the University of Gent (Belgium) to carry out a study on the biological role, content in feed and requirements in animal nutrition of selected trace and ultratrace elements, including manganese. The findings were submitted to EFSA in the form of a technical report (Van Paemel et al., 2010) . Information from this report has been used in this opinion.
EFSA has verified the European Union Reference Laboratory (EURL) report as it relates to the methods used for the control of manganese (five compounds, including: manganous chloride, tetrahydrate; manganous oxide; manganous sulphate, monohydrate; manganese chelate of amino acids, hydrate; manganese chelate of glycine, hydrate) in animal feed. The Executive Summary of the EURL report can be found in the Annex. 
Methodologies
The (EFSA FEEDAP Panel, 2012b) , Guidance for establishing the safety of additives for the consumer (EFSA FEEDAP Panel, 2012c) , Guidance on studies concerning the safety of use of the additive for users/workers (EFSA FEEDAP Panel, 2012d).
Assessment
The opinion is based on data provided by the companies joint in the application Consortium 12 involved in the production/distribution of manganese-containing compounds, and publicly available literature. It should be recognised that these data cover only a fraction of the existing manganese-based additives placed on the market.
The additives under assessment are: manganous chloride, tetrahydrate; manganous oxide; manganous sulphate, monohydrate; manganese chelate of amino acids, hydrate; manganese chelate of glycine, hydrate. These compounds are already authorised in the EU for use in feed. Additionally, some of the compounds are applied for use in water. Therefore, a re-evaluation of authorisation, or a new use of an additive is sought, depending on the compound (see Table 1 ). 
Characterisation and identity
Manganese chloride tetrahydrate is formed by reacting elemental manganese with hydrochloric acid (37%). The solution is concentrated by evaporation and the resulting manganese chloride crystals are isolated, dried and packaged. 22.5.2008, p. 1. 12 At the time of submission the application represented 12 companies joint as a Consortium; during the assessment, the compound (manganous carbonate) represented by company b10 was withdrawn from the dossier; therefore, it has not been considered in the current opinion. The product is a solid, pink in colour and odourless. Its solubility in water at 25°C is 723 g/L. It has a bulk density at 20°C of 0.800 g/cm 3 .
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The additive contains by specification ≥ 27.0% manganese. The company provided analytical data of six batches showing a manganese content of 27-33%.
16,17
Levels of heavy metals (Pb< 0.5 mg/kg product; Cd< 0.5 mg/kg product; Hg 0.02 mg/kg product) and As (< 0.05 mg/kg product) 18 analysed in three batches comply with the thresholds set in Directive 2002/32/EC for compounds of trace elements or, if not mentioned in the Directive, do not represent a safety concern. Dioxins and the sum of dioxins and dioxin-like polychlorinated biphenyls (PCBs) were analysed in three batches showing 0.09-0.31 ng WHO-PCDD/F-TEQ/kg and 0.12-0.47 ng WHO-PCDD/F-PCB-TEQ/kg, respectively; 19 these concentrations comply with those set in Directive 2002/32/EC. The nickel content was < 15 mg/kg. 20 Particle size distribution was characterised in four batches of the product by laser diffraction; 21, 22 the percentage of particles with diameter < 50 µm ranged from 0% to 3.67%, and that of particles < 10 µm ranged from 0% to 0.02%. Dusting potential of the product (data from three batches, Stauber-Heubach method) ranged from 0.02 to 0.15 g/m 3 .
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Stability and homogeneity
Stability data are not required for inorganic compounds of trace elements.
No experimental data on the homogeneous distribution of the additive were provided. Instead, the theoretical Jansen method (Jansen, 1992) was applied to estimate the homogeneity of the product in a premixture and in a piglet feed. 24 However, this method has been developed to test the working accuracy of mixing equipment and it is not accepted by the FEEDAP Panel as a valid method for assessing the homogeneity of distribution of additives in feeds. Because of the high solubility in water of the compound, no further demonstration of homogeneity is deemed necessary. 25 'Manganous oxide' (CAS No 1344-43-0) has the chemical formula MnO (molecular weight 70.94 Da; theoretical manganese content 77.39%).
Manganous oxide
Characterisation and identity
The raw materials are manganese ore and a reduction agent (coke). After selection and weighing, the raw materials are transferred into a rotate dryer for blending and elimination of the moisture in the mixture. A grinding process follows, to obtain the defined particle size, and then sieved. The sieved particles are taken to a dosage silo subsequently into an oven, where the calcination occurs at approximately 900°C. After cooling, the material goes through a final sieve; the sieved material finally goes to a storage silo. The material is then weighed and packed. The chemical composition of the product and the content of heavy metals is monitored. The plants have a Hazard Analysis Critical Control Points (HACCP) protocol implemented.
The product is a solid, brown-green coloured powder, odourless. It is insoluble in water. It has a density of 5.4 g/cm 3 and a bulk density of 1.6-1.9 g/cm 3 .
26
The additive contains by specification ≥ 60.0% manganese. The measured manganese content of the product (five batches per company) was of 60.3-62.7%. For further details regarding characterisation and identity of manganous oxide, see Appendix C, Particle size distribution was characterised in one batch from each company (by laser diffraction); 30. 4-41.5% (v/v) of the particles had a diameter of < 52.6 µm, and 13. 7-23.0% (v/v) of the particles had a diameter of < 10.8 µm. Stauber-Heubach analysis of a single batch of the product with the highest fraction of particles with diameter < 50 µm indicated a dusting potential of 4.22 g/m 3 ; additionally, the particle size of the dust of the product from the same company gave a result of 40.1% of particles with diameter < 50 µm.
28
Stability and homogeneity
Stability data are not required for inorganic compounds of trace elements. Nevertheless, company b7 provided data on the shelf-life of the additive. Three batches were stored in closed bags at ambient conditions. 29 The manganese content of the product, analysed by inductively coupled plasma atomic emission spectrometry, did not change over a period of at least 3 years, indicating that manganous oxide is stable.
No experimental data on the homogeneous distribution of the additive were provided. Instead, the theoretical Jansen method (Jansen, 1992) was applied to estimate the homogeneity of the product in a broiler feed. 30 However, this method has been developed to test the working accuracy of mixing equipment and it is not accepted by the FEEDAP Panel as a valid method for assessing the homogeneity of distribution of additives in feeds. 
Manganous sulphate, monohydrate
Characterisation and identity
Two manufacturing processes were reported in the technical dossier. In one, manganous oxide is mixed with sulphuric acid, pressed and filtered; since precipitation occurs, the non-soluble impurities are removed. The crude manganous sulphate solution is obtained and purified by crystallisation. After dehydration and drying, the product is packed and labelled.
In the other manufacturing process, manganous oxide is first produced from manganese dioxide by calcination. Sulphuric acid is added to produce manganous sulphate. The content of iron and cadmium 27 Technical Dossier/Supplementary Information (August 2015) . 28 Technical Dossier/Supplementary Information (April 2015)/Annex_Qiia_Mn oxide_particle_size_dust.pdf. 29 Technical Dossier/Section II/Annex 2-4-2. 30 Technical Dossier/Section II/Annex 2-4-14. 31 Two companies involved in the application: (b7) and (b12).
is reduced by chemical and physical processes. The manganous sulphate solution is heated. The dried product is packed and labelled accordingly.
The whole production is performed under HACCP protocols.
The product is a solid, grey-pink crystalline powder, odourless. Its solubility in water at 20°C is 762 g/L. The density is 3.25 g/cm 3 and the bulk density ranged from 1.18 to 1.25 g/cm 3 .
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The additive contains by specification ≥ 31.0% manganese. The measured manganese content of the product (four to six batches per company) was 31.4-34.1%. For further details regarding characterisation and identity of manganous oxide, see Appendix C, Table 4 .
Levels of heavy metals (Pb < 0.5-33 mg/kg product; Cd 0.57-16 mg/kg product; Hg < 0.01-< 0.2 mg/kg product, four to six batches from three companies) and As (< 0.5-9.7 mg/kg product), measured in four to six batches from each company, and F (< 70 mg/kg product) measured in one batch from company b7, comply with the thresholds set in Directive 2002/32/EC for compounds of trace elements or, if not mentioned in the Directive, do not represent a safety concern. Dioxins (analysed in two to four batches per company) and the sum of dioxins plus dioxin-like PCBs (two to five batches from three companies) were 0.047-0.09 ng WHO-PCDD/F-TEQ/kg and 0.073-0.138 ng WHO-PCDD/F-PCB-TEQ/kg, respectively; these concentrations comply with those set in Directive 2002/32/EC. The nickel content was analysed in a total of seven production batches, revealing a content ranging from 23 to 891 mg/kg.
Particle size distribution was characterised in one batch from each company (by laser diffraction); up to 6.5% (v/v) of the particles had a diameter of < 52.6 µm, and up to 1.6% of the particles had a diameter of < 10.8 µm. Stauber-Heubach analysis of a single batch of the product with the highest fraction of particles with diameter < 50 µm indicated a dusting potential of 6.9 g/m 3
; the particle size of the dust was requested but not provided.
Stability and homogeneity
No experimental data on the homogeneous distribution of the additive were provided. Instead, the theoretical Jansen method (Jansen, 1992) was applied to estimate the homogeneity of the product in a broiler starter feed. 33 However, this method has been developed to test the working accuracy of mixing equipment and it is not accepted by the FEEDAP Panel as a valid method for assessing the homogeneity of distribution of additives in feeds. Because of the high solubility in water of the compound, no further demonstration of homogeneity is deemed necessary.
Manganese chelate of amino acids, hydrate
34
'Manganese chelate of amino acids, hydrate' is described by the applicant with the generic chemical formula Mn(x) [1] [2] [3] •nH 2 O, where x is the anion of any amino acid derived from hydrolysed soya protein, molecular weight not exceeding 1500 Da.
35
Characterisation and identity
The manufacturing process starts with enzymatic hydrolysis of soybean protein (under specific pH conditions). The hydrolysis process is followed by chelation with a source of manganese. The slurry is dried and packed. The applicant confirmed that only unblended products are placed on the EU market by the companies participating in this application as no anticaking/carrier or other diluents are added. 36 The applicant provided a generic process flow chart.
32 Technical Dossier/Section II/Annexes 2-2-16 and 2-2-17. 33 Technical Dossier/Section II/Annex 2-4-11. 34 Seven companies involved in the application: (b1), (b2), (b3), (b4), (b8), (b9) and (b12). During the course of the evaluation, the applicant notified that companies b3 and b8 are no longer defending this additive within the current application; no Supplementary Information was provided by those companies and therefore they were disregarded from the relevant assessment. 35 The product is a solid, off-white to tan marbeled free-flowing powder, with a characteristic odour. It is reported to be dispersable in water. The product has a density of 1.4 g/cm 3 and the bulk density ranges from 0.4 to 0.7 g/cm 3 .
37
The additive contains by specification ≥ 10.0% manganese. The manganese content of 25 batches of the additive (three to seven batches from each company) was 10.2-16.7%. The applicant was requested to provide data on the proportions of manganese chelate and any inorganic manganese. The applicant developed an indirect method (based on Fourier Transform Infrared (FTIR) spectroscopy) to estimate the binding of manganese to amino acids. The values were quantified by comparison with a calibration curve. The results of this in-house method, although validated, are not considered fully reliable but allow the conclusion that between 35% and 100% of total manganese occurs as chelates.
Analytical data of nine batches (company/ies not specified) was provided showing the percentage of molecules with molecular weight ≤ 1500 Da. Considering all values, up to 30% of the molecules exceeded 1500 Da. The FEEDAP Panel notes that the specification of the applicant on the molecular weight of the compound 'not exceeding 1500 Da' is not met by analytical data, and does not comply with current legislation (Commission Regulation (EC) No 1334/2003).
The applicant provided the analysis of five batches of the hydrolysate material before the addition of the manganese source for free and total amino acids; the lysinoalanine content was also analysed showing to be below 50 mg/100 g.
Proximate analysis of a total of four batches (one batch from each of four companies) of the additive revealed a content of 2.9-8.9% moisture, and on an as is basis: 24.1-31.7% crude protein (nitrogen × 6.25), 0.0-1.4% lipids, 1.4-2.6% crude fibre and 26.4-46.4% ash; the mineral fraction consists of 0.3-0.7% calcium, 6.8-9.7% sulphur, 0.1-2.6% sodium, 1.1-1.3% potassium and 0.2-0.4% phosphorus. 38, 39, 40, 41 For further details regarding characterisation and identity of manganese chelate of amino acids, hydrate, see Appendix C, Tables 5 and 6 . Levels of heavy metals (Pb < 0.05-20 mg/kg and Cd < 0.1-7 mg/kg, at least one batch of the product from each company; Hg < 0.005- < 0.5 mg/kg, 10 batches from four companies), As (< 0.1-1 mg/kg at least one batch from each company) and fluorine (F) (< 0.10 mg/kg, three batches from one company) comply with the thresholds set in Directive 2002/32/EC for compounds of trace elements, or, if not mentioned in the Directive, do not represent a safety concern. Dioxins (analysed in a total of 10 batches from the five companies) and the sum of dioxins plus dioxin-like PCBs (analysed in one to three batches from four companies) were 0.015-0.16 ng WHO-PCDD/F-TEQ/kg and 0.016-0.318 ng WHO-PCDD/F-PCB-TEQ/kg, respectively; these concentrations comply with those set in Directive 2002/32/EC. The nickel content was analysed in a total of seven production batches (at least one batch per company) revealing a content ranging from 11 to 472 mg/kg.
The analysis of mycotoxins in seven batches of the product from five companies did not raise concern (aflatoxin B1 and ochratoxin A were found at a maximum concentration of 0.35 μg/kg and below 0.5 μg/kg, respectively). In the batches stored from 1 to 40 months, the content of moulds, yeasts and total coliforms was below 100 CFU (colony-forming units)/g; Salmonella was absent in 25 g of the product.
Particle size distribution was characterised in one to four batches per company by laser diffraction or sieving. The fraction of particles with diameter below 50 μm ranged from approximately 4% to 73%, and that below 10 μm ranged from 0% to 22.5%. Dusting potential (Stauber-Heubach method) was determined only in five batches of the product identified as having the highest percentage of particles < 50 µm, and was up to 0.88 g/m³; the manganese content of the dust was analysed in four batches 37 Technical Dossier/Section II/Annex 2-2-1 (b1), Annex 2-2-2 (b2), Annex 2-2-4 (b4), Annex 2-2-6 (b9) and and showed an average of 10.50% (range 9.8-11.3%).
42 Due to the small amount of dust collected, the particle size distribution of the dust could not be determined.
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Stability and homogeneity
No stability (including shelf-life) data were provided for the manganese chelate of amino acids, hydrate, in particular concerning the maintenance of the specific bonds of manganese in the chelates. The FEEDAP Panel recognises the analytical difficulties to demonstrate stability of these specific bonds and notes that the active substance is also unlikely to disappear in these products.
The product was shown to be stable to microbial contamination for 1-40 months (see Characterisation and identity).
Experimental data on the capacity for homogeneous distribution of the additive were provided by company b1. Manganese content was determined in 15 samples of a complementary feed for horses containing manganese chelate of amino acids, hydrate; the mean concentration was 411 mg total Mn/kg, the coefficient of variation (CV) was 0.97%. 'Manganese chelate of glycine, hydrate' is derived from synthetic glycine mixed with a manganese salt. It has the generic formula Mn(x) [1] [2] [3] •nH 2 O, where x is the anion of glycine.
Characterisation and identity
To produce manganese chelate of glycine, hydrate, a manganese salt (sulphate, carbonate) or any other source of manganese is mixed with synthetic glycine; the raw materials could be of any source that complies with EU Regulations. The chelation reaction conditions are controlled and monitored. Then the product is dried. The applicant confirmed that only unblended solid products are placed on the EU market by the companies participating in this application.
The product is a solid, odourless, beige to pink free-flowing powder. Its solubility in water is >10 g/L. The product has a density of 0.97 g/cm 3 and the bulk density ranges from 0.79 to 0.92 kg/m 3 .
46
The additive contains by specification ≥ 15.0% manganese. The manganese content of 34 batches of the additive, at least three batches from each company, ranged from 15.8% to 27.0% -the large range results primarily from the different ratios of manganese to glycine. For further details regarding characterisation and identity of manganese chelate of glycine, hydrate, see Appendix C, Table 7 .
Additional data on 10 batches showed that the manganese content ranged from 16.2% to 22.7%, extractable glycine from 32.2% to 51.0%, sulphur from 9.5% to 15.2% and moisture from 0.4% to 5.2%. The molar ratio of glycine to manganese in the different products ranged from 3.1 to 1.4 47 (see also Appendix C, Table 8 ).
Levels of heavy metals (Pb < 0.5-34 mg/kg, Cd < 0.5-4 mg/kg, analysed in at least three batches per company; Hg < 0.5 mg/kg, three batches each from three companies) and As (<001-1 mg/kg, one to five batches per company) comply with the thresholds set in Directive 2002/32/EC for compounds of trace elements, or, if not mentioned in the Directive, do not represent a safety concern. Dioxins (analysed in one to five batches from each company) and the sum of dioxins plus dioxin-like PCBs (one to five batches from three companies) were 0.018-0. Microbial contamination was analysed in one batch at 0, 24 and 48 h after dilution in water. 48 At all time points studied, total aerobic count, moulds and yeasts were below 1 CFU/g, and Salmonella was not detected in 25 g sample of the product.
Particle size distribution was characterised in one to three batches per company by laser diffraction. The products differed markedly in their particle size distribution. For one group of additives 100% of particles showed a diameter < 50 μm, with up to 93.5% of particles < 10 μm. The fraction < 50 μm in the other group of additives amounted up to approximately 11%; the fraction < 10 μm ranged from approximately 0.8 to 4%. Dusting potential (Stauber-Heubach method) was determined only in one batch of the product identified as having the highest percentage of particles < 50 µm and was 2.23 g/m³. The particle size of the dust was analysed in one batch of the additive of company b2 showing 53.4% of particles of diameter < 10 μm. The manganese content of the dust was not provided, although requested.
Stability and homogeneity
No stability (including shelf-life) data were provided for the manganese chelate of glycine, hydrate, in particular concerning the maintenance of the specific bonds of manganese in the chelate. The FEEDAP Panel recognises the analytical difficulties to demonstrate stability of this specific bond and notes that the active substance is also unlikely to disappear in these products.
Experimental data on the capacity for homogeneous distribution of the additive were provided by company b11. Manganese content was determined in eight samples of a premixture containing manganese chelate of glycine, hydrate; the mean concentration was 35 mg total Mn/kg, indicating a CV of 5.7%. 
Physico-chemical incompatibilities
On the basis of current knowledge, no incompatibilities resulting from the use of manganese in compound feed are expected, other than those widely known and considered by feed manufacturers in diet formulation.
The applicant provided data on the influence of manganese chelate of glycine, hydrate, or manganese sulphate monohydrate (10 mg Mn/L) on the stability of vitamins A, D 3 and E in a liquid vitaminmineral mixture, also containing iron, copper and zinc. The vitamin concentration was compared to a control mixture, without addition of trace elements, after 2 weeks of storage. The three vitamins were stable in the presence of the trace element sources tested. 
Conditions of use
All manganese compounds under application are intended to be administered to feedingstuffs via a premixture. The use of three compounds (manganous chloride, tetrahydrate; manganous sulphate, monohydrate; manganese chelate of glycine, hydrate) is also applied for use in water for drinking for all animal species and categories, except fish (for details, see Table 2 ).
The maximum manganese contents proposed for water for drinking are derived from the maximum contents set for complete feed by a factor (ratio of water/feed intake) of 7 for milk replacer, of 10 for ovine and of 2-3 for other species (see Table 2 ). It is noted that the provided manganese calculations for use in water for drinking do not consider the background manganese content in feed. 48 Technical Dossier/Supplementary Information (April 2015)/Annex_Qxxiv_Mn glycinate_stability water_microbio (T0).pdf.
Annex_Qxxiv_Mn glycinate_stability water_microbio (T24).pdf. Annex_Qxxiv_Mn glycinate_stability water_microbio (T48).pdf. 49 Technical Dossier/Section II/Annex 2.4.9. 50 Technical Dossier/Section II/Annex 2.4.15. Manganese is an essential trace element in livestock nutrition. Its essentiality in livestock nutrition (poultry) became evident in the 1930s (Lyons and Insko, 1937; Wilgus et al. 1937; Schaible et al., 1938) .
Manganese has a long history of safe use in animal feeding. In general, manganese is considered to be one of the least toxic essential trace elements for farm animals. Depressed iron status and haematological changes are the most common signs of manganese toxicosis, also observed in animals fed adequate levels of iron (NRC, 2005) . The National Research Council defined in 2005 maximum tolerable levels (MTL, in mg/kg DM) for ruminants and poultry (2000), pigs (1000) and horses (400), whereas no MTL could be derived for fish because of insufficient data (NRC, 2005) . The current authorised maximum total contents in complete feed in the EU (100 mg/kg for fish and 150 mg/kg for other animal species) provide a sufficient margin of safety to the MTLs as well as a sufficient margin of safety to the allowances, with estimated requirements for chicken and turkeys for fattening of 60 mg/kg, for laying hens of 30 mg/kg, for pigs and cattle of 15-25 mg/kg (GfE, 1999 (GfE, , 2001 (GfE, , 2008 NRC, 1994 NRC, , 2001 Suttle, 2010) .
Regarding the use of some of the compounds in water for drinking, it appears that the maximum manganese concentration in water for drinking as proposed by the applicant (Table 2 ) was derived from calculations in which no manganese background of feed and a low water intake of animals (mainly only 2 L/kg feed) were considered. For poultry, pigs and calves (fed milk replacer), 50, 33 and 18 mg Mn/L water for drinking were derived, respectively, as safe maximum concentrations; the corresponding values for dairy cows are 2,405 mg Mn/day and for cattle for fattening 240 mg Mn/100 kg bw (body weight) (for further details, see Appendix D).
The FEEDAP Panel notes that the above calculated maximum manganese concentrations and daily doses that could be applied via water for drinking can only be used if feed not supplemented with manganese is given. It is also noted that the calculations do not consider the manganese content of water for drinking. Consequently, the FEEDAP Panel reiterates its recommendation that compounds of trace elements should generally not to be used via water for drinking (EFSA, 2010b).
As the additives contain nickel as a contaminant, the FEEDAP Panel assessed the impact of nickel on safety for the target species. According to the NRC (2005), horses, fish and rodents are the most sensitive animal species to nickel with a MTL of 50 mg/kg feed. In the worst-case scenario, the nickel that would be added to the feed if supplemented with manganese chelate of amino acids, hydrate would amount to less than 0.5 mg/kg feed for horses. Together with the background nickel in feed (i.e. 4 or 9 mg/kg DM feed; Nicholson et al., 1999; Van Paemel et al., 2010; EFSA CONTAM Panel, 2015) , the total nickel would then amount up to 9.44 mg Ni/kg feed, corresponding to approximately 20% of MTL of the sensitive animal species. Therefore, the nickel content of the additives does not represent a safety concern for the target species.
Interactions
Manganese and iron compete for absorption sites. Fibre, phytate, calcium, phosphorus and magnesium may also interfere with manganese absorption. The manganese compounds under assessment are not expected to show any relevant interactions with feed components other than those well recognised for manganese.
Conclusions on the safety for the target species
The FEEDAP Panel concludes that all the manganese compounds under application are considered safe for all animal species/categories, provided that the current maximum total contents of manganese authorised in feed (100 mg/kg complete feedingstuffs for fish and 150 mg/kg for other species) are respected.
Safety for the consumer Metabolic and residue studies
Manganese is absorbed through the small intestine by non-saturable simple diffusion (Bell et al., 1989) or by a carrier-mediated transport mechanism with high affinity and low capacity (GarciaAranda et al., 1983) . Typical apparent absorption may be in the range of 3-5%; however, values as high as 40% have been observed in veal calves with a supply of only 0.6 mg Mn/kg milk replacer (Kirchgessner and Neese, 1976) . Absorption in poultry is lower, explaining the higher requirement.
Intestinal absorption of manganese is also inversely related to iron intake (Lönnerdal, 1997).
Manganese absorbed into portal circulation is transported by α 2 -macroglobulins or albumin to the liver. The major portion of manganese in the liver is secreted into bile. Consequently, manganese is primarily excreted via faeces. Urinary excretion of manganese is only a minor route of excretion; it reflects endogenous homeostatic regulation and is not related to the dietary intake (NRC, 2005).
The highest concentrations of manganese are found in the liver, pancreas and kidney and the lowest levels occur in bone and fat. Nevertheless, manganese deposition in any of these tissues is not considered a valuable indicator of manganese availability in the gut (Jongbloed et al., 2002) .
Manganese deposition studies
Residue/deposition studies are not required for an already approved compound of trace elements.
The applicant provided a report of publications comparing organic and inorganic manganese compounds based on a total of 14 experiments performed with manganese combined with other minerals (seven with Cu/Fe/Zn, six with Cu/Zn and one Cu/Fe). The table in Appendix E summarises the data of these studies on manganese deposition in liver, muscle or eggs.
In four experiments (Mabe et al, 2003; Ao and Pierce, 2006; Huyghebaert, 2006; Dobrzanski et al., 2008) , organic manganese sources did not influence the manganese content of the egg (total, egg yolk and egg albumin) differently to inorganic sources.
Only one study (Kinal et al., 2007) comparing the effect of organic and inorganic manganese sources on manganese content of milk was submitted; no differences were found.
Another comparison of inorganic and organic manganese sources was made regarding manganese in liver (one study in broilers (Bao et al., 2007) , two in piglets Martin et al., 2011) and two in dairy cows Nocek et al., 2006) ). The results showed no evidence for different deposition of manganese in liver between the two manganese sources in four of the five studies submitted. Nevertheless, one study (Martin et al., 2011) showed that manganese in liver was increased when a diet with an organic manganese source was fed.
Four studies reported manganese deposition in muscle following supplementation with organic and inorganic sources. One study in piglets (Martin et al., 2011) showed that deposition in muscle occurred at very low level upon supplementation with either an organic or an inorganic source, albeit manganese deposited in muscle was higher with the organic source. One study in chickens for fattening (Petrovic et al., 2010) reported no differences in manganese muscle deposition between organic and inorganic sources. Two studies in rainbow trout were available, yielding different results: Apines et al. (2003) observed a twofold increase in whole body manganese when supplementation was done by the organic source; however, this finding was not confirmed by a subsequent publication of the same group (Apines et al., 2004) . The overall evidence suggests that muscle tissue is not an important deposition site for manganese, irrespective of the supplementation source.
Toxicological profile of manganese. Toxicological reviews
Manganese is essential in the nutrition of both animals and humans. The FEEDAP Panel reviewed the relevant literature and considered several previous toxicological assessments of manganese. It is noted that there are relatively limited data available on oral toxicity in laboratory animals and humans.
As is the case for all transition metals, long-term exposure to high doses of manganese poses a risk. The toxicology of manganese has been reviewed by the Scientific Committee on Food (SCF) (EC, 2000) , the UK Expert Group on Vitamins and Minerals (EVM 2002 (EVM , 2003 , the US Environmental Protection Agency (EPA, 2003) , the UK Institute of Environment and Health (IEH, 2007) and most recently the US Agency for Toxic Substances and Disease Registry (ATSDR, 2012). The toxicology of manganese has been recently reviewed by Lucchini et al. (2015) . There is a consensus that the main toxic effects of manganese in humans concern the nervous system, the respiratory system (inhalatory exposure) and, to a lesser extent, the reproductive system.
Chronic severe toxicity is primarily associated with effects on the central nervous system (CNS), especially through inhalation and long-term exposure, and is considered much more relevant than acute effects (Huang et al., 1989; cited by IEH, 2007) . Common neurological symptoms arising from chronic manganism tend to occur in phases and start with anorexia, weakness and apathy, followed by a second phase of hallucinations, delusions and insomnia. During the later stages of chronic toxicity, Parkinson-like symptoms such as tremor and muscle rigidity take place. Although manganism and true idiopathic Parkinson disease cause very similar deficits within the CNS, they differ in the neurotransmitters upon which they act; manganese toxicity results principally in the degeneration of γ-aminobutyric acid-ergic neurons in the globus pallidus whilst Parkinson disease is more associated with the dopaminergic neurons in the basal ganglia (Roth, 2006; cited by IEH, 2007) .
Manganese aggregates into non-haem iron regions of the brain such as the globus pallidus, substantia nigra and subthalamic nuclei (Aschner et al., 2007) . Although the precise mechanisms by which manganese induces toxic effects within the CNS are a matter of continuing debate, there are a number of reports which highlight possible interactions between manganese and other trace elements such as iron, copper and aluminium (IEH, 2007) . Postulated mechanisms of manganese-induced neurotoxicity include (i) increased production of reactive oxygen species (Cohen, 1984; cited by IEH, 2007) ; (ii) neuronal degeneration by means of activation of glutamate-gated channels (Brouillet et al., 1993; cited by IEH, 2007) ; (iii) manganese in a divalent (or higher) oxidation state exerting toxicity on dopamine (Archibald and Tyree, 1987; cited by IEH, 2007) ; (iv) dopamine oxidation by manganese causing oxidative DNA damage (Oikawa et al., 2006 , cited by IEH, 2007 ; and (v) production of 6-hydroxydopamine (or other toxic catecholamines; Graham, 1984; cited by IEH, 2007) . Another publication focuses on dopamine oxidation and mitochondrial damage as the main mode of action (Farina et al., 2013) .
There are association studies suggesting that, as in animal models, excess manganese exposure in humans can lead to reproductive toxicity, resulting in decreased fertility and increased foetal abnormalities (Lauwerys et al., 1985; cited by IEH, 2007; Crossgrove and Zheng, 2004; cited by IEH, 2007) . For example, in one study, manganese-exposed male workers were found to have fewer children than others (Lauwerys et al., 1985; cited by IEH, 2007) . However, other studies did not find the same effect (IEH, 2007) .
The results of in vitro studies show that at least some chemical forms of manganese have mutagenic potential (ATSDR, 2012) . The issue of manganese genotoxicity has been recently reconsidered by Lima et al. (2011) ; available data confirm that manganese can exert genotoxic effects in human lymphocytes ex vivo without any marked concurrent cytotoxicity. Likely mechanisms include oxidative damage (as a transition metal, manganese is a potential reactive oxygen species inducer) and the interaction with DNA polymerases and other proteins involved with DNA-dependent processes (Wafik et al., 1984) . The results of in vivo studies in rodents are inconsistent, and in its assessment of manganese, ATSDR (2012) was unable to draw an overall conclusion about the possible genotoxic hazard to humans from exposure to manganese compounds.
Information on in vivo chronic toxicity of manganese comes from the National Toxicology Program (NTP), which conducted two chronic studies in rats and mice (NTP, 1993) . F344/N rats were exposed orally for 2 years to manganese from manganous sulphate at 60, 200 or 465 mg/kg bw (males) or 70, 230 or 714 mg/kg bw (females). Under the conditions of this 2-year feeding study, there was no evidence of carcinogenic activity of manganese (II) sulphate monohydrate in male or female rats (NTP, 1993) . In a 2-year study in B6C3F1 mice, the animals were exposed orally to 160, 540 or 1,800 mg Mn/kg bw (males) or 200, 700 or 2,250 mg Mn/kg bw (females). There was equivocal evidence 51 of carcinogenic activity of manganese (II) sulphate monohydrate in male and female mice, based on a marginally increased incidence of thyroid gland follicular cell adenoma and a significantly increased incidence of follicular cell hyperplasia. The ingestion of diets containing manganese (II) sulphate monohydrate was associated with focal squamous hyperplasia of the forestomach in male and female mice, and ulcers and inflammation of the forestomach in male mice. EVM (2002) echoed the conclusions by NTP (1993) and stated that 'Chronic carcinogenicity studies of manganese sulphate in mice and rats were essentially negative, with equivocal evidence of carcinogenicity being observed in mice only'. There is no epidemiological or other evidence suggesting that manganese causes cancer in humans (ATSDR, 2012; Lucchini et al., 2015) .
Assessment of consumer safety
See previous FEEDAP Panel opinions on re-evaluation of manganese compounds as feed additives (EFSA FEEDAP Panel, 2013a , 2013b , 2013c .
Conclusions on safety for consumers
The usual intake levels of dietary manganese do not appear to be associated with any adverse health effects in humans, albeit it is advisable that oral exposure to manganese should not increase over the background intake. Tissues and products of animal origin generally provide a low contribution to the overall manganese dietary intake and are not influenced to any important degree by the supplementation of feeds at the current maximum authorised levels in the EU, irrespective of whether the source is inorganic or organic. Moreover, due to the long history of use of manganese supplementation of feed for food-producing animals, the dietary intake data in humans are expected to include foods derived from animals reared with manganese-supplemented feed. It is concluded that the use of the manganese compounds under assessment in animal nutrition is of no concern for the safety of consumers, provided that the current maximum total contents of manganese authorised in feed are respected. 
Safety for users/workers
No specific studies were provided by the applicant regarding the toxicity of the additives for users/workers.
Effects on skin and eyes
Two of the compounds under assessment, manganous sulphate and manganous chloride, react acidic at contact with water; these salts are considered as irritants after contact with eyes and mucosae, but not irritating or sensitisers to skin (Ikarashi et al., 1992; Basketter et al., 1999; ATSDR, 2012; Lucchini et al., 2015) . 53 Another additive, the insoluble manganous oxide, is not a skin irritant or skin sensitiser, but may mechanically irritate the eyes after exposure (ATSDR, 2012) . 54 The limited 51 'Equivocal evidence' of carcinogenic activity is demonstrated by studies that are interpreted as showing a marginal increase in neoplasms that may be chemical related (NTP, 1993) . 52 100 mg total Mn/kg for fish and 150 mg total Mn/kg for other species. database available 55 indicates that the manganese chelate of glycine, hydrate and the manganous chelate of amino acid, hydrate may irritate skin and eyes and, for the latter, owing to its proteinaceous nature, should be considered as a skin sensitiser. The presence of nickel in the additives may induce contact dermatitis in workers.
Effects on the respiratory system
Manganese is a recognised workplace toxicant upon inhalation exposure. Inhalation of manganese can result in pulmonary oedema and tracheobronchitis (Nemery, 1990; cited by IEH, 2007) . Furthermore, inhaled manganese is particularly hazardous as it can be transported directly to the brain, bypassing the intestinal absorption control and liver metabolism (ATSDR, 2012) . Some studies suggest that manganese inhalation can result in adverse cognitive effects, such as attention deficit and amnesia (ATSDR, 2012) as well as parkinsonism-like symptoms (Park, 2013) . Individuals subject to prolonged occupational exposure to high levels of manganese are considered to be most at risk. Thus, welders, miners and other metal industry workers have increased incidence of pulmonary conditions such as pneumonia and bronchitis (Saric and Piasek, 2000; cited by IEH, 2007) . The lung epithelium functions as a barrier to infection and its ability to respond to foreign antigens is disrupted in the presence of manganese along with many other transition metals. In a study by Roth and Garrick (2003; cited by IEH, 2007) , manganese was regarded as the second most important metal, after copper, in causing inflammation of the lung tissue. This inflammation is thought to occur by means of cytokine release (interleukins) as opposed to being immunoglobulin E mediated.
All manganese compounds under assessment have fractions of particle sizes < 50 µm (i.e. inhalable) exceeding 1%. The dusting potentials are in the range between 0.15 g/m 3 (manganese chelate of amino acids) and 6.9 g/m 3 (manganous sulphate monohydrate). Therefore, exposure of workers/users by inhalation when handling the product is likely to be high. Moreover, some of the additives are water soluble and can potentially be absorbed by the epithelium of the upper respiratory tract to become available to the circulatory system. The human body has an effective control system which normally prevents the intestinal absorption of an excess of manganese from the diet; however, this system is bypassed upon inhalation exposure of soluble manganese compounds. The FEEDAP Panel considered whether the presence of nickel in the additives under evaluation would pose additional concerns to the safety of users. The nickel content of the additives under assessment was provided and reached concentrations close to 900 mg/kg of the additive for manganous sulphate, monohydrate and manganous oxide. Inhalation of soluble nickel can cause pulmonary toxicity, resulting in bronchitis, fibrosis and lung cancer in humans. The proposed occupational exposure limit (OEL) for the inhalable fraction of water-soluble nickel is 0.01 mg/m 3 (EC, 2011) . Considering the dusting potential and the nickel content of the additives, the nickel released in the dust from handling manganous sulphate, monohydrate and manganese chelate of glycine hydrate is more than two orders of magnitude higher than the proposed OEL, that of chelate of amino acids, hydrate one order of magnitude.
Conclusions on safety for the users/workers
Manganese chloride, tetrahydrate, manganous sulphate, hydrate and manganous oxide are not irritants to skin or dermal sensitisers; these three compounds should be considered as eye irritants. It is prudent to regard the manganese chelate of glycine, hydrate, and the manganous chelate of amino acid, hydrate, as irritants to skin and eyes, and the amino acid chelate as a dermal sensitiser.
Due to the high dusting potential, all manganese compounds under assessment can cause respiratory toxicity in persons handling the additive.
The nickel content in the dust of manganous sulphate, monohydrate, manganese chelate of glycine hydrate and the manganese chelate of amino acids, hydrate represents a risk by inhalation. Moreover, the presence of nickel in all additives may induce contact dermatitis in users.
Safety for the environment
Manganese is the second most abundant (after iron) transition element in the Earth's crust, with an estimated global average in soil of 437 mg/kg (Forum of European Geological Surveys, FOREGS), 56 ranging from 40 to 900 mg/kg (Lucchini et al., 2015) . The median concentration of manganous oxide in 845 samples of topsoil collected throughout Europe for the FOREGS survey was 650 mg/kg and the manganese content of the acid-soluble fraction (Aqua regia) contained 382 mg/kg, with a range of < 10-6,480 mg/kg (FOREGS). The behaviour of manganese in soil is very complex and is controlled by different environmental factors, of which pH-Eh conditions are the most important (Kabata-Pendias 2001) . Mn 2+ appears to have low affinity for organic ligands (Lazerte and Burling, 1990; Chiswell and Zaw 1991 
Environmental safety from use in feeds for terrestrial farm animals
Based on the calculation method provided in the technical guidance for assessing the safety of feed additives for the environment (EFSA, 2008b) , the highest theoretical addition of manganese in soil (PEC soil ) from animal feeds is around 3 mg/kg (lambs) after a 1-year application of manure assuming that 100% of a dose will be excreted. As the median content of manganese in European soil is over two orders of magnitude higher than this value, the use of manganese in animal feeds at the legislated inclusion levels is not expected to pose a risk to the soil compartment.
Environmental safety from use in aquaculture feeds
Using its technical guidance for assessing the safety of feed additives for the environment (EFSA, 2008b) , the FEEDAP Panel calculated the worst-case concentrations in the environment resulting from the supplementation of fish feeds with the manganese compounds under assessment at the total level of 100 mg Mn/kg. When fed to fish in sea cages, the sediment under the cage is considered the compartment of concern (EFSA, 2008b). The PEC sed was calculated to be 21.2 mg/kg wet weight, which substantially exceeds the threshold for Phase I assessment (10 μg/kg). However, manganese concentrations in top sediment in marine and estuarine environments vary widely from 10 to at least 4,000 mg/kg, which in all cases by far exceeds that maximally emitted from aquaculture (Sadiq and Zaidi, 1985; Cahill and Unger, 1993; Galasso et al., 2000; Sahli et al., 2011) . For land-based aquaculture operations, such as ponds and raceways, the surface water downstream of the fish farm is considered the most sensitive compartment (EFSA, 2008b) . The PEC swaq was calculated to be 0.07-0.25 μg /L, depending on the species. This concentration slightly exceeds the trigger value, but is yet two orders of magnitude lower than the median concentration of manganese in European freshwaters (FOREGS).
Conclusions on environmental safety
The use of the manganese compounds under assessment (manganous chloride, tetrahydrate; manganous sulphate, monohydrate; manganous oxide; manganese chelate of amino acids, hydrate; manganese chelate of glycine, hydrate) in animal nutrition for all animal species is safe for the environment, provided that the current maximum total contents of manganese authorised in feed are respected.
Efficacy
No efficacy studies are required for compounds of trace elements already authorised as feed additives.
The use of the manganese compounds under assessment in animal nutrition is extensively documented in the scientific literature and summarised by McDowell (2003) and Suttle (2010) . They are recognised as efficacious sources of manganese in meeting animals' requirements.
Post-market monitoring
The FEEDAP Panel considers that there is no need for specific requirements for a post-market monitoring plan other than those established in the Feed Hygiene Regulation 57 and good manufacturing practice.
Conclusions
The manganese compounds under consideration are: manganous chloride, tetrahydrate; manganous sulphate, monohydrate; manganous oxide; manganese chelate of amino acids, hydrate and manganese chelate of glycine, hydrate. The safety assessment is based on the assumption that the current maximum total contents of manganese authorised in feed are respected.
Recommendations
For all manganese compounds, monitoring of the nickel content, and for manganous oxide monitoring of mercury content, should be included in the HACCP plan. Attempts should be made for a continuous reduction in the nickel content.
Concerning the manganese chelate of amino acids, hydrate, the FEEDAP Panel identified in a previous assessment (EFSA FEEDAP Panel, 2013b ) and in the current one that the description of the compound does not meet the terms of the current legislation: 'molecular weight not exceeding 1500 dalton'. 
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